Free Trial
CVE:IGX

IntelGenx Technologies (IGX) Stock Price, News & Analysis

IntelGenx Technologies logo
C$0.58 +0.01 (+1.75%)
As of 10/6/2021

About IntelGenx Technologies Stock (CVE:IGX)

Key Stats

Today's Range
C$0.58
C$0.60
50-Day Range
C$0.58
C$0.58
52-Week Range
C$0.17
C$0.85
Volume
11,848 shs
Average Volume
56,279 shs
Market Capitalization
C$87.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IGX Stock News Headlines

Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion.tc pixel
IntelGenx: Q1 Earnings Snapshot
Stocks in play: IntelGenx Corp.
IntelGenx Launches Preferred Share Regulation A Offering
See More Headlines

IGX Stock Analysis - Frequently Asked Questions

IntelGenx Technologies' stock was trading at C$0.58 at the beginning of 2025. Since then, IGX stock has increased by 0.0% and is now trading at C$0.58.

Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that IntelGenx Technologies investors own include IntelGenx Technologies (IGXT), F-star Therapeutics (FSTX), Trican Well Service (TCW), Aurora Cannabis (ACB), New Age Brands (NF), AutoZone (AZO) and Bonterra Energy (BNE).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Chemicals
Current Symbol
CVE:IGX
CIK
N/A
Fax
N/A
Employees
2,050
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
164.62
Current Ratio
2.77
Quick Ratio
2.69

Sales & Book Value

Annual Sales
C$1.75 million
Price / Sales
49.95
Cash Flow
C$0.08 per share
Price / Cash Flow
7.16
Book Value
C$0.05 per share
Price / Book
12.89

Miscellaneous

Outstanding Shares
150,546,000
Free Float
N/A
Market Cap
C$87.32 million
Optionable
Not Optionable
Beta
N/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (CVE:IGX) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners